Table of Contents Author Guidelines Submit a Manuscript
Dermatology Research and Practice
Volume 2009, Article ID 715729, 2 pages
Case Report

Response of Fibroblastic Rheumatism to Infliximab

Departments of Dermatology and Rheumatology, University of São Paulo, 05403-000 São Paulo, SP, Brazil

Received 9 August 2009; Accepted 11 November 2009

Academic Editor: Thomas Ruzicka

Copyright © 2009 Ricardo Romiti et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. N. Kluger, A. Dumas-Tesici, D. Hamel, N. Brousse, and S. Fraitag, “Fibroblastic rheumatism: fibromatosis rather than non-Langerhans cell histiocytosis,” Journal of Cutaneous Pathology. In press.
  2. I. M. L. Marconi, M. C. Rivitti-Machado, M. N. Sotto, and M. M. S. Nico, “Fibroblastic rheumatism,” Clinical and Experimental Dermatology, vol. 34, no. 1, pp. 29–32, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus